Published June 27, 2020
| Version v6
Working paper
Open
Ivermectin for Covid-19
Description
Discussion of scholar papers published until June 27, 2020, on Ivermectin, and of news that we can find about its use for Covid-19. A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv, which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19. From news, we consider in particular the case of Iquitos, capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably.
Notes
Before reading this work, please consider that I am not a physician. I do not suggest the use of ivermectin. I am not touting this drug. This analysis of publications and news about ivermectin is made in the framework of a wider investigation about information concerning drugs used for Covid-19.
Files
Ivermectin-5.pdf
Files
(188.4 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:8efca629cb06da7d3cf9b72b8e93ee2f
|
188.4 kB | Preview Download |